AURAAura Biosciences Inc. Common Stock
7.800USD+0.13%Mkt Cap: 808.90M $P/E: —3d ago
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like par…